Rationale and applications of lipids as prodrug carriers

European Journal of Pharmaceutical Sciences

Volumn 11, Issue SUPPL. 2, 2000, Pages

  Lambert, Didier M ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

Drug delivery; Fatty acids; Glycerides; Phospholipids; Prodrugs

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLSALICYLIC ACID; ACICLOVIR; ACYLGLYCEROL; ALCLOFENAC; ALKYLATING AGENT; ANTHELMINTIC AGENT; ANTICONVULSIVE AGENT; ANTIVIRUS AGENT; BUPRANOLOL; CHLORAMBUCIL; CLOSANTEL; DRUG CARRIER; FATTY ACID; FENOPROFEN; FLUPENTIXOL; GLYCINE; IBUPROFEN; INDOMETACIN; LEVODOPA; LIPID; MELPHALAN; NAPROXEN; NEUROLEPTIC AGENT; NICLOSAMIDE; NIFLUMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEOSIDE ANALOG; PHENYTOIN; PHOSPHOLIPID; PRODRUG; THIORPHAN; VALPROIC ACID; VIGABATRIN;

CONFERENCE PAPER; CONJUGATE; DRUG DELIVERY SYSTEM; PRIORITY JOURNAL;

ANIMAL; CENTRAL NERVOUS SYSTEM; DRUG CARRIERS; FATTY ACIDS; GLYCERIDES; HEPATOCYTES; HUMAN; LIPIDS; LYMPH; PHOSPHOLIPIDS; PRODRUGS; TRIGLYCERIDES;

EID: 0033796167     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(00)00161-5     Document Type: Conference Paper

References (93)

1. Chemical aspects of selective toxicity
2. Pancreatic lipase-catalyzed hydrolysis of esters of hydroxymethyl phenytoin dissolved in various metabolizable vehicles, dispersed in micellar systems, and in aqueous suspensions
3. Polyiodinated triglyceride lipid emulsions for use as hepatoselective contrast agents in CT: of physicochemical properties on biodistribution and imaging
4. Physicochemical characterization of a synthetic lipid emulsion for hepatocyte-selective delivery of lipophilic compounds: application to polyiodinated triglycerides as contrast agents for computed tomography
5. 14C-labelled fatty acids in normal and diabetic rat myocardium in vivo
6. Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin
7. Molecular cloning of a human gastric lipase and expression of the enzyme in yeast
8. 14C]palmitate
9. Gastric lipase: crystal structure and activity
10. Structural basis for the substrate selectivity of pancreatic lipases and some related proteins
11. Pharmacological studies in the rat with [2-(1,3-didecanoyloxy)-propyl]2-acetyloxybenzoate (A-45474): an aspirin pro-drug with negligible gastric irritation
12. Targeting of drug to the hepatocytes by fatty acids. Influence of the carrier (albumin or galactosylated albumin) on the fate of the fatty acids and their analogues
13. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy
14. Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors
15. Novel anti-inflammatory agents
16. Synthesis and in vitro study of a diglyceride prodrug of a peptide
17. In vitro evaluation of filaricidal activity of GABA and 1,3-dipalmitoyl-2-(4-aminobutyryl)glycerol HCl: a diglyceride prodrug
18. Synthesis of the orally macrofilaricidal and stable glycerolipidic prodrug of melphalan,1,3-dipalmitoyl-2-(4'[bis(2''-chloroethyl)amino]phenylalaninoyl)glycerol
19. In vitro and in vivo evaluation of macrofilaricidal activity of GABA and 1,3-dipalmitoyl-2-(4-aminobutyryl)glycerol HCl: a diglyceride prodrug
20. Incorporation of xenobiotic carboxylic acids into lipids
21. Xenobiotic lipids: the inclusion of xenobiotic compounds in pathways of lipid biosynthesis
22. Metabolism of fenbufen by cultured 3T3-L1 adipocytes: synthesis and metabolism of xenobiotic glycerolipids
23. Synthesis and orally macrofilaricidal evaluation of niclosamide lymphotropic prodrugs
24. Synthesis and evaluation of the anti-inflammatory effects of niflumic acid lipophilic prodrugs in brain edema
25. Lipophilic xenobiotic conjugates: the pharmacological and toxicological consequences of the participation of drugs and other foreign compounds as substrates in lipid biosynthesis
26. Design and applications of prodrugs
27. Evaluation of nonionic nitroxyl lipids as potential organ-specific contrast agents for magnetic resonance imaging
28. Evaluation of a nitroxyl fatty acid as liver contrast agent for magnetic resonance imaging
29. 1,3-dipalmitoylglycerol ester of chlorambucil as a lymphotropic, orally administrable antineoplastic agent
30. A lymphotropic prodrug of L-Dopa: synthesis, pharmacological properties, and pharmacokinetic behavior of 1,3-dihexadecanoyl-2-[(S)-2-amino-3-(3,4-dihydroxyphenyl)propanoyl]propane-1,2,3-triol
31. N-(benzyl-oxycarbonyl)glycine esters and amides as new anticonvulsants
32. The metabolism of the xenobiotic triacylglycerols, rac-1- and sn-2-(3-phenoxybenzoyl)-dipalmitoylglycerol, following intravenous administration to the rat
33. The metabolism of 3-phenoxybenzoic acid-containing xenobiotic triacylglycerols in vitro by pancreatic, hormone-sensitive and lipoprotein lipases
34. 1-beta-D-arabinofuranosylcytosine-phospholipid conjugates as prodrugs of Ara-C
35. Nucleoside conjugates. 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-1,2-dipalmitins
36. Acyclovir diphosphate dimyristoylglycerol: a phospholipid prodrug with activity against acyclovir-resistant herpes simplex virus
37. γ-aminobutyric acid esters. 2. Synthesis, brain uptake, and pharmacological properties of lipid esters of γ-aminobutyric acid
38. γ-aminobutyric acid esters. 3. Synthesis, brain uptake, and pharmacological properties of C-18 glyceryl lipid esters of GABA with varying degree of unsaturation
39. Synthesis, brain uptake, and pharmacological properties of lipid esters of a glyceryl lipid containing GABA and the GABA-T inhibitor γ-vinyl-GABA
40. Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate
41. 14C] palmitate, iodopalmitate and iodophenylpentadecanoate in isolated rat hearts. A contribution to the choice of an iodinated fatty acid as a tracer of myocardial metabolism
42. 14C]carboxylbenzoyl glycerol
43. Analgesic potency of S-acetylthiorphan after intravenous administration in mice
44. 1,3-Diacylaminopropan-2-ols and corresponding 2-acyl derivatives as drug carriers: unexpected pharmacological properties
45. Anticonvulsant activities of N-benzyloxycarbonylglycine after parenteral administration
46. Glyceride conjugate as drug carriers
47. Synthesis and pharmacological properties of 2-[S-acetylthiorphan]-1,3- diacylaminopropan-2-ol derivatives as chimeric lipid drug carriers containing an enkephalinase inhibitor
48. 14C]-glycine, a lipophilic derivative of glycine
49. Des derives simples de la glycine aux systemes lipidiques transporteurs de glycine. Essai de vectorisation d'un acide amine neutre de petite taille vers le systeme nerveux central
50. Anticonvulsant activity of ester- and amide-type lipid conjugates of glycine and N-benzyloxycarbonylglycine
51. The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic?
52. Lymphotropic antifilarial agents derived from closantel and chlorambucil
53. Study of lymphotropic targeting and macrofilaricidal activity of a melphalan prodrug on the Molinema dessetae model
54. Formulation of polyiodinated triglyceride analogues in a chylomicron remnant-like liver-selective delivery vehicle
55. Phase behaviour of a diglyceride prodrug: spontaneous formation of unilamellar vesicles
56. Interactions of anti-inflammatory 2-arylpropionates (profens) with the metabolism of fatty acids - in vitro studies
57. Synthesis of 1,3-diacylamino-2-propanols and corresponding 2 acyl derivatives as amide isosteres of natural lipids
58. Antiepileptic activity of 1,3-dihexadecanoylamino-2-valproyl-propan-2-ol, a prodrug of valproic acid endowed with a tropism for the CNS
59. Xenobiotic triacylglycerol formation in isolated hepatocytes
60. Glycerides as prodrugs. 1. Synthesis and antiinflammatory activity of 1,3-bis(alkanoyl)-2-(O-acetylsalicyloyl)glycerides (aspirin triglycerides)
61. Glycerides as prodrugs. 2. 1,3-Dialkanoyl-2-(2-methyl-4-oxo-1,3-benzodioxan-2-yl)glycerides (cyclic aspirin triglycerides) as antiinflammatory agents
62. Glycerides as prodrugs. 3. Synthesis and antiinflammatory activity of [1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetyl]glycerides (indomethacin glycerides)
63. Glycerides as prodrugs. 4. Synthesis and antiinflammatory activity of 1,3-dialkananoyl-2-arylalkanoylglycerides
64. Design de vecteurs micromoleculaires de medicaments
65. 123I-phenylpentadecanoic acid as a tracer of cardiac free fatty acid metabolism. Experimental and clinical results
66. Deacylation-reacylation cycle: a possible absorption mechanism for the novel lymphotropic antitumor agent dipalmitoyl-phosphatidylfluorouridine in rats
67. Potential organ or tumor imaging agents. 32. A triglyceride ester of p-iodophenyl pentadecanoic acid as a potential hepatic imaging agent
68. Phenytoin-lipid conjugates as potential prodrugs of phenytoin
69. Phenytoin-lipid conjugates: chemical, plasma esterase-mediated, and pancreatic lipase-mediated hydrolysis in vitro
70. Synthesis and in vitro evaluation of 4-(2-glyceryl)butyric acid: a glyceride mimic for drug delivery via drug-lipid conjugates
71. Anticonvulsant activity of phenytoin-lipid conjugates, a new class of phenytoin prodrugs
72. Bioavailability and anticonvulsant activity of a monoglyceride-derived prodrug of phenytoin after oral administration to rats
73. Bioavailability of phenytoin following oral administration of phenytoin-lipid conjugates to rats
74. Bioavailibility and anticonvulsant activity of phenytoin-bis-hydroxybutyrate after oral administration to rats
75. Pancreatic lipase drug delivery with glyceride-containing prodrugs
76. Studies on intestinal lymphatic absorption of drugs. I. Lymphatic absorption of alkyl ester derivatives and alpha-monoglyceride derivatives of drugs
77. Studies on intestinal lymphatic absorption of drugs. II. Glyceride prodrugs for improving lymphatic absorption of naproxen and nicotinic acid
78. Lymphatic absorption of hypolipidemic compound,1-O-[p-(myristyloxy)-alpha-methylcinnamoyl]glycerol (LK-903)
79. Synthesis of a new class of camptothecin derivatives, the long-chain fatty acid esters of 10-hydroxycamptothecin, as a potent prodrug candidate, and their in vitro metabolic conversion by carboxylesterases
80. Radionuclide assessment of myocardial fatty acid metabolism by PET and SPECT
81. Drug metabolism
82. Prodrugs revisited: the ad hoc approach as a complement to ligand design
83. Phosphoglyceride metabolism
84. Colipase: structure and interaction with pancreatic lipase
85. Antiviral nucleoside diphosphate diglycerides: improved synthesis and facilitated purification
86. Synthesis and antiviral activity of 3'-azido-3'-deoxythymidine triphosphate distearoylglycerol: a novel phospholipid conjugate of the anti-HIV agent AZT
87. Potential tumor- or organ-imaging agents. 26. Polyiodinated 2-substituted triacylglycerols as hepatropic agents
88. Potential tumor- or organ-imaging agents. 27. Polyiodinated 1,3-disubstituted and 1,2,3-trisubstituted triacylglycerols
89. Polyiodinated triglyceride analogs as potential computed tomography imaging agents for the liver
90. Computed tomography scanning of hepatic tumors with polyiodinated triglycerides
91. Designing prodrugs and bioprecursors. I. Carrier prodrugs